Patent Assignment
Reel/Frame 055113/0241
Assignment of Assignor's Interest
Recorded: 2021-02-02
Pages: 15
Assignor
IMMUNOCORE LTD.
Executed: 2021-02-02
Assignees
IMMUNOCORE LIMITED
92 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, OX14 4RY, UNITED KINGDOM
ADAPTIMMUNE LIMITED
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, OX14 4RX, UNITED KINGDOM
Covered Properties
(36)
Peptides Derived from Kallikrein 4
Application:
15/777,155 →
Publication:
US 2018/0334663
Peptides
Application:
15/777,180 →
Publication:
US 2018/0334476
Peptides
Application:
15/777,629 →
Publication:
US 2018/0334485
Peptides
Application:
15/777,874 →
Publication:
US 2018/0346514
Peptides
Application:
15/777,882 →
Publication:
US 2018/0371039
Peptides
Application:
15/777,885 →
Publication:
US 2018/0346546
Peptides Derived from P Antigen Family Member 2 (PAGE2)
Application:
15/777,888 →
Publication:
US 2018/0346547
Peptides of PAGE5
Application:
15/777,892 →
Publication:
US 2018/0371040
Peptides from PIWIL1
Application:
15/778,175 →
Publication:
US 2018/0346515
Claudin-6 Peptides
Application:
16/097,587 →
Publication:
US 2019/0161528
Peptides Derived from P Antigen Family Member 2 (PAGE2)
Application:
16/985,058 →
Publication:
US 2021/0017250
Peptides
Application:
16/985,061 →
Publication:
US 2021/0017227
Peptides
Application:
16/988,425 →
Publication:
US 2021/0032301
Peptides
Application:
16/988,431 →
Publication:
US 2021/0017228
Peptides Derived from Transient Receptor Potential Cation Channel Subfamily M Member 1 (TRPM1), Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
16/988,523 →
Publication:
US 2021/0093732
Peptides from PIWIL1
Application:
16/994,399 →
Publication:
US 2021/0061857
Peptides Derived from Actin-Like Protein 8 (ACTL8)
Application:
16/997,731 →
Publication:
US 2021/0145936
Peptides Derived from Kallikrein 4
Application:
16/998,945 →
Publication:
US 2021/0047629
Peptides
Application:
17/010,653 →
Publication:
US 2021/0054045
Peptides
Application:
17/013,228 →
Publication:
US 2021/0054036
Claudin-6 Peptides
Application:
17/017,444 →
Publication:
US 2021/0061874
Peptides of PAGE5
Application:
17/017,457 →
Publication:
US 2021/0054037
Peptides of Bromodomain Testis-Specific Protein (Brdt)
Application:
17/031,691 →
Publication:
US 2021/0101949
Peptides Derived from Kita-Kyushu Lung Cancer Antigen (KKLC1, CT83, CXORF61) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/065,509 →
Publication:
US 2021/0121526
Peptides Derived from Lengsin (Lgsn), Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/083,158 →
Publication:
US 2021/0123037
Peptides
Application:
17/087,363 →
Publication:
US 2021/0122794
Peptides Derived from Melanoma-Associated Antigen C2 (MAGEC2) and Uses Thereof
Application:
17/092,691 →
Publication:
US 2021/0121551
Progesterone-Associated Endometrial Protein (Paep) and Uses Thereof
Application:
17/092,715 →
Publication:
US 2021/0121547
Peptides Derived from Solute Carrier Family 45 Member 2 (SLC45A2) and Uses Thereof
Application:
17/092,970 →
Publication:
US 2021/0122784
Peptides Derived from Achaete-Scute Homolog 2 (ASCL2), Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/099,242 →
Publication:
US 2021/0122798
Peptides Derived from Prorelaxin H1 (RLN1)
Application:
17/099,267 →
Publication:
US 2021/0147505
Peptides
Application:
17/099,286 →
Publication:
US 2021/0122803
Peptides Derived from Prostate Specific Antigen (KLK3) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/104,415 →
Publication:
US 2021/0138054
Peptides
Application:
17/104,668 →
Publication:
US 2021/0139558
Peptides Derived from Homeobox Protein B13 (Hox-B13) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/104,677 →
Publication:
US 2021/0170003
Peptides Derived from Sarcoma Antigen 1 (SAGE1 ) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/105,010 →
Publication:
US 2021/0171594
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 15, 2019
From: CHESTER, FIONA; POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 048888/0986 →
Assignment of Assignor's Interest
Apr 15, 2019
From: POPA, ALINA; POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 048888/0758 →
Assignment of Assignor's Interest
Apr 15, 2019
From: CHESTER, FIONA; POPA, ALINA; POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 048888/0529 →
Assignment of Assignor's Interest
Sep 6, 2019
From: POWLESLAND, ALEX; CHESTER, FIONA; DELLACRISTINA, PIETRO; CHILLAKURI, CHANDRAMOULI
To: IMMUNOCORE LIMITED
Reel/Frame 050299/0172 →
Assignment of Assignor's Interest
Dec 3, 2019
From: POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 051167/0596 →
Assignment of Assignor's Interest
Dec 13, 2019
From: POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 051281/0767 →
Assignment of Assignor's Interest
Dec 18, 2019
From: POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 051327/0058 →
Assignment of Assignor's Interest
Feb 27, 2020
From: HOOD, GRAHAM
To: IMMUNOCORE LIMITED
Reel/Frame 051954/0587 →
Assignment of Assignor's Interest
Feb 27, 2020
From: POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 051956/0270 →
Security Interest
Nov 6, 2020
From: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
To: OXFORD FINANCE LUXEMBOURG S.À R.L., REGISTERED WITH THE LUXEMBOURG COMMERCIAL REGISTER UNDER NUMBER B243395, ACTING IN RESPECT OF ITS COMPARTMENT 1
Reel/Frame 054344/0218 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0785 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX; POPA, ALINA; CHESTER, FIONA
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0820 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0961 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0971 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX; CHESTER, FIONA; DELLACRISTINA, PIETRO; CHILLAKURI, CHANDRAMOULI
To: IMMUNOCORE LIMITED
Reel/Frame 054913/0822 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX; KLEIJNEN, MAURITS
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0920 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX; CHILLAKURI, CHANDRAMOULI; SANGANI, DHAVAL; POPA, ALINA
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0251 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX; CHESTER, FIONA; POPA, ALINA
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0297 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX; POPA, ALINA; ADDIS, PHILIP
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0331 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX; POPA, ALINA
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0384 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX; KLEIJNEN, MAURITS
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0482 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX; CHESTER, FIONA
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0498 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX; POPA, ALINA
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0510 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0531 →
Assignment of Assignor's Interest
Jan 6, 2021
From: POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 054835/0780 →